Cargando…

P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE

Detalles Bibliográficos
Autores principales: Romano, A., Parrinello, N. L., Scandura, G., Marino, S., Triolo, A., Del Fabro, V., Di Raimondo, F., Conticello, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171773/
http://dx.doi.org/10.1097/01.HS9.0000936300.90717.ee
_version_ 1785039494812008448
author Romano, A.
Parrinello, N. L.
Scandura, G.
Marino, S.
Triolo, A.
Del Fabro, V.
Di Raimondo, F.
Conticello, C.
author_facet Romano, A.
Parrinello, N. L.
Scandura, G.
Marino, S.
Triolo, A.
Del Fabro, V.
Di Raimondo, F.
Conticello, C.
author_sort Romano, A.
collection PubMed
description
format Online
Article
Text
id pubmed-10171773
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101717732023-05-11 P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE Romano, A. Parrinello, N. L. Scandura, G. Marino, S. Triolo, A. Del Fabro, V. Di Raimondo, F. Conticello, C. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171773/ http://dx.doi.org/10.1097/01.HS9.0000936300.90717.ee Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster
Romano, A.
Parrinello, N. L.
Scandura, G.
Marino, S.
Triolo, A.
Del Fabro, V.
Di Raimondo, F.
Conticello, C.
P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE
title P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE
title_full P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE
title_fullStr P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE
title_full_unstemmed P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE
title_short P43 CIRCULATING CLONAL PLASMA CELLS AT START OF SALVAGE REGIMEN PROVIDE POWERFUL PROGNOSTICATION BIOMARKER IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE
title_sort p43 circulating clonal plasma cells at start of salvage regimen provide powerful prognostication biomarker in multiple myeloma patients at first relapse
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171773/
http://dx.doi.org/10.1097/01.HS9.0000936300.90717.ee
work_keys_str_mv AT romanoa p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse
AT parrinellonl p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse
AT scandurag p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse
AT marinos p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse
AT trioloa p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse
AT delfabrov p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse
AT diraimondof p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse
AT conticelloc p43circulatingclonalplasmacellsatstartofsalvageregimenprovidepowerfulprognosticationbiomarkerinmultiplemyelomapatientsatfirstrelapse